Risk factors for neurodevelopmental deficits in congenital hypothyroidism after early substitution treatment

Kaiming Huo1, Zhan Zhang, Dehua Zhao

  • 1Department of Pediatrics, the Third Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.

Endocrine Journal
|April 7, 2011
PubMed

Insights

Children with congenital hypothyroidism (CH) may experience subtle neurodevelopmental deficits. Factors like CH severity, thyroid stimulating hormone (TSH) normalization time, and socioeconomic status influence outcomes.

Area of Science:

  • Pediatric Endocrinology
  • Neurodevelopmental Pediatrics
  • Genetics

Background:

  • Congenital hypothyroidism (CH) requires early treatment for optimal neurodevelopment.
  • Subtle neurological deficits can persist despite early intervention in CH patients.
  • Understanding factors influencing neurodevelopmental outcomes is crucial for CH management.

Purpose of the Study:

  • To evaluate factors influencing neurodevelopmental outcomes in children with congenital hypothyroidism.
  • To compare developmental quotients (DQ) of CH patients with healthy controls.

Main Methods:

  • Gesell Developmental Schedules (GDS) used to assess DQ at 24 months in 155 CH patients and 310 controls.
  • Analysis of factors including CH severity, serum T4 levels, thyroid stimulating hormone (TSH) normalization time, and parental socioeconomic status.
  • Bivariate correlation and multiple regression analyses were employed.

Main Results:

  • CH patients showed significantly lower mean DQ scores for adaptive behavior compared to controls (p < 0.01).
  • Severe CH, low serum T4 at diagnosis, and longer TSH normalization time were associated with lower adaptive behavior scores (p < 0.0003).
  • CH severity, TSH normalization time, and parental socioeconomic status significantly correlated with DQ scores.

Conclusions:

  • Neurodevelopmental deficits in CH are linked to CH severity, TSH normalization time, and socioeconomic status.
  • Early detection and management of CH, considering these influencing factors, are vital for improving long-term neurodevelopmental outcomes.

Related Concept Videos

Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...